Lifetech Scientific Overview
- Founded
- 1999
- Status
- Public
- Employees
- 778
- Stock Symbol
- 01302
- Investments
- 4
- Share Price
- $0.63
- (As of Thursday Closing)
Lifetech Scientific General Information
Description
LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: congenital and structural heart diseases; peripheral vascular diseases; and cardiac pacing. The congenital heart diseases business sells congenital heart defect occluders. The peripheral vascular diseases segment contributes the largest proportion of revenue and sells products such as vena cava filters, stent grafts, and vascular plugs. The cardiac pacing segment sells pacemakers. LifeTech Scientific distributes products worldwide but generates the majority of its revenue in China.
Contact Information
Website
Formerly Known As
Shenzhen Lifetech Technology Co.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Diagnostic Equipment
Stock Exchange
HKG
Primary Office
- Lifetech Scientific Building, NO.22, Keji 12th Road South
- Hi-tech Industrial Park, Nanshan District
- Shenzhen, 518057
- China
+86 0755 0000 0000
Lifetech Scientific Timeline
Lifetech Scientific Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.63 | $0.61 | $0.17 - $0.67 | $2.82B | 4.63B | 44.7M |
Lifetech Scientific Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 1,362,002 | 832,839 | 797,574 | 977,719 |
| Revenue | 90,043 | 96,804 | 84,153 | 60,540 |
| EBITDA | 31,733 | 35,296 | 29,741 | 30,883 |
| Net Income | 19,303 | 18,699 | 18,303 | 24,190 |
| Total Assets | 266,401 | 253,291 | 222,581 | 194,489 |
| Total Debt | 56,091 | 50,516 | 3,492 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Lifetech Scientific Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Lifetech Scientific‘s full profile, request access.
Request a free trialLifetech Scientific Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| XIE Yuehui | Chief Executive Officer, Chairman & Executive Director | ||
| Liu Jianxiong | Vice President, Chief Financial Officer, Company Secretary and Executive Director |
Lifetech Scientific Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| XIE Yuehui | Lifetech Scientific | Chief Executive Officer, Chairman & Executive Director | 000 0000 |
Lifetech Scientific Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialLifetech Scientific Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Lifetech Scientific‘s full profile, request access.
Request a free trialLifetech Scientific Investments (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 00000 000 | 04-Jun-2019 | 00000 0000000 | Pharmaceuticals | 000 000000 | |
| 00000 00000 000000 | 03-Apr-2019 | 00000 0000000 | Surgical Devices | 000 000000 | |
| 00000 | 21-May-2018 | 00000 00000 00 | 00000 | Biotechnology | 000 000000 |
| Broncus Medical | 22-May-2012 | Later Stage VC | Therapeutic Devices |